BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37665053)

  • 1. Amelioration of the therapeutic potential of gefitinib against breast cancer using nanostructured lipid carriers.
    Kumar P; Mangla B; Javed S; Ahsan W; Aggarwal G
    Nanomedicine (Lond); 2023 Aug; 18(18):1139-1160. PubMed ID: 37665053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation.
    Poonia N; Kaur Narang J; Lather V; Beg S; Sharma T; Singh B; Pandita D
    Colloids Surf B Biointerfaces; 2019 Sep; 181():756-766. PubMed ID: 31234063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating
    Sartaj A; Annu ; Biswas L; Verma AK; Sahoo PK; Baboota S; Ali J
    Biomed Res Int; 2022; 2022():6009309. PubMed ID: 35155677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines.
    Chand P; Kumar H; Badduri N; Gupta NV; Bettada VG; Madhunapantula SV; Kesharwani SS; Dey S; Jain V
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111535. PubMed ID: 33360926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
    Singh A; Neupane YR; Mangla B; Kohli K
    J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured Lipid Carrier-Based Gel for Repurposing Simvastatin in Localized Treatment of Breast Cancer: Formulation Design, Development, and In Vitro and In Vivo Characterization.
    Kumbhar PS; Manjappa AS; Shah RR; Nadaf SJ; Disouza JI
    AAPS PharmSciTech; 2023 Apr; 24(5):106. PubMed ID: 37085596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line.
    Kamel AE; Fadel M; Louis D
    Int J Nanomedicine; 2019; 14():5073-5085. PubMed ID: 31371948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition.
    Rapalli VK; Sharma S; Roy A; Singhvi G
    Colloids Surf B Biointerfaces; 2021 Oct; 206():111945. PubMed ID: 34216849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of S(+)-zaltoprofen oral bioavailability using nanostructured lipid carrier system.
    Pham TMA; Lee DH; Na YG; Jin M; Jung M; Kim HE; Yoo H; Won JH; Lee JY; Baek JS; Han SC; Lee HK; Cho CW
    Arch Pharm Res; 2022 Nov; 45(11):822-835. PubMed ID: 36307644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma.
    Harshita ; Barkat MA; Rizwanullah M; Beg S; Pottoo FH; Siddiqui S; Ahmad FJ
    AAPS PharmSciTech; 2019 Jan; 20(2):87. PubMed ID: 30675689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
    Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
    Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane:
    Mangla B; Neupane YR; Singh A; Kumar P; Shafi S; Kohli K
    Nanomedicine (Lond); 2020 Nov; 15(26):2563-2583. PubMed ID: 33079004
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and
    Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K
    Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment.
    Soni NK; Sonali LJ; Singh A; Mangla B; Neupane YR; Kohli K
    Nanotechnology; 2020 Nov; 31(47):475101. PubMed ID: 32886644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentapeptide cRGDfK-Surface Engineered Nanostructured Lipid Carriers as an Efficient Tool for Targeted Delivery of Tyrosine Kinase Inhibitor for Battling Hepatocellular Carcinoma.
    Deepak P; Kumar P; Pandey P; Arya DK; Jaiswal S; Kumar A; Sonkar AB; Ali D; Alarifi S; Ramar M; Rajinikanth PS
    Int J Nanomedicine; 2023; 18():7021-7046. PubMed ID: 38046236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.